IRadimed Corp
NASDAQ:IRMD
IRadimed Corp
Net Income (Common)
IRadimed Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRadimed Corp
NASDAQ:IRMD
|
Net Income (Common)
$17.2m
|
CAGR 3-Years
132%
|
CAGR 5-Years
22%
|
CAGR 10-Years
24%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is IRadimed Corp's Net Income (Common)?
Net Income (Common)
17.2m
USD
Based on the financial report for Dec 31, 2023, IRadimed Corp's Net Income (Common) amounts to 17.2m USD.
What is IRadimed Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
24%
Over the last year, the Net Income (Common) growth was 34%. The average annual Net Income (Common) growth rates for IRadimed Corp have been 132% over the past three years , 22% over the past five years , and 24% over the past ten years .